Daily Dose - Jan 14th, 2026
Daily Dose |
View online
January 14, 2026
JPM26: Thermo Fisher’s pharma services business benefits from US reshoring
CEO Marc Casper told the J.P. Morgan Healthcare Conference that the company has won contracts to help its customers move production to this country.
Read More
WuXi Biologics facilities receive UK GMP certification
The UK’s Medicines and Healthcare products Regulatory Agency clears two sites in Wuxi, China, for commercial ophthalmic biologic manufacturing and packaging.
Read More
Asimov licenses lentiviral packaging cell line to AGC Biologics
The agreement adds a single-plasmid lentiviral vector manufacturing option at AGC’s Milan cell and gene therapy site.
Read More